“…1-3,9,13,17,19,21,22,28,31,34,35,41,44,46,50,53,57,66 Pain improved from 28% to 54% and function from 9% to 32% at 5 to 13 weeks postinjection compared with baseline. 8 The most recent review found a moderate benefit of VS for pain reduction (effect size [ES], −0.37; 95% CI, 0.46 to −0.28) compared with placebo or no intervention.…”